1. Modified SMILE (mSMILE) and Intensity-Modulated Radiotherapy ...
26 aug 2020 · mSMILE is a short course, intensive regimen incorporating pegylated asparaginase. Here we describe clinical details, outcome and safety of patients receiving ...
A modification of the SMILE regimen with dexamethasone, methotrexate, ifosfamide, L-asparaginase, etoposide (mSMILE) followed by Intensity-Modulated Radiotherapy (IMRT) at lower than usual dose, has been adopted as standard of care for extranodal NK/T ...
2. National Smile Month 2024 launch event celebrates oral health and ...
21 jun 2024 · Running under the theme of 'Love Your Smile,' National Smile Month aims to inspire people to prioritise oral health and wellbeing.
BDJ Team - National Smile Month 2024 launch event celebrates oral health and wellbeing
3. 4041-Modified SMILE - eviQ
The modified SMILE (mSMILE) regimen is associated with significant haematological and non-haematologic toxicity and careful consideration of patient fitness ...
Central venous access device (CVAD) is required to administer this treatment.
4. [PDF] SMILE-TB Trial - Johns Hopkins University
a new regimen that replaces rifampicin and ethambutol with two powerful antibiotics, rifapentine and moxifloxacin.
5. Smile Art Contest 2024 - Westcoast International Dental Clinic Vietnam
Building on the success of previous years, we are thrilled to announce the launch of the Smile Art Contest 2024, under the inspiring theme: “EXPLORE VIETNAMESE ...
2024 celebrates the 9th anniversary of the Westcoast Dental’s Smile Art Contest. This competition serves as an engaging platform for children aged 12.
6. 1552-SMILE (dexamethasone methotrexate iFOSFamide ... - eviQ
Bevat niet: theme | Resultaten tonen met:theme
It is the consensus of the Haematology Reference Committee to discontinue this protocol as native E-coli asparaginase (colaspase) is no longer available. It is the view of the committee that protocols with evidence for pegaspargase use in the trials supporting them be recommended rather than substituting pegaspargase into native E-coli asparaginase containing protocols. See ID 4041 NK T-Cell lymphoma modified SMILE (dexamethasone methotrexate iFOSFamide pegaspargase etoposide).
7. Efficacy and Safety of a Pegasparaginase-Based ...
16 jun 2022 · The DDGP regimen was well tolerated and showed statistically significant survival benefit over the SMILE regimen in treating newly diagnosed ENKL.
This randomized clinical trial compares the efficacy and safety of the DDGP (dexamethasone, cisplatin, gemcitabine, and pegaspargase) regimen with the SMILE (dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide) regimen in newly diagnosed advanced-stage (III/IV) extranodal natural...
8. Overview of the current treatment strategy in extranodal NK/T-cell ...
... Regimen Versus SMILE Regimen. Blood 2019;134:463. [Crossref]; Yamaguchi M ... All content on this site: Copyright © 2024 AME Publishing Company. All ...
Overview of the current treatment strategy in extranodal NK/T-cell lymphoma: from diagnosis to recurrence